abstract |
Disclosed are compositions and methods for the treatment and / or prevention of disorders associated with C1 esterase inhibitor deficiency. A pharmaceutical composition comprising a C1 esterase inhibitor and sodium citrate having a pH range of 6.5 to 8.0, wherein the C1 esterase inhibitor is about 400 to 600 U / ml. A pharmaceutical composition, wherein the C1 esterase inhibitor comprises a specific amino acid sequence. [Selection figure] None |